Gross
					
						 - "Furthermore, the coadministration of Shikonin, a potent PKM2 inhibitor, reverted the tumor development induced by the HMGCR signaling pathway.Species-specific monitoring activities represent fundamental tools for […]"View
					
				 
				Active 8 months, 4 weeks ago